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SEthics: A Problem in Pharmacy?
Keith I. Yoshizuka, PharmD, MBA, JD, FCSHP
What’s the big deal about ethics in pharmacy? Isn’t ethics simply the discipline dealing  with what is right and wrong and with moral duty and obligation?1 The American 
Pharmacists Association even has its own Code of Ethics.2 The evidence suggests 
that, on occasion, ethics is a problem with pharmacists. The June 2017 edition of the 
California State Board of Pharmacy Newsletter, The Script, lists 27 pharmacists who 
were subject to disciplinary action by the Board, and were required to take a course in 
ethics within 60 calendar days of the hearing as a condition of keeping their license 
to practice pharmacy.3 The requirements for such a course are codified in the California 
Code of Regulations §1773.5.4 Isn’t ethics simply the discipline dealing with what is right 
and wrong and with moral duty and obligation?5
Contemporary biomedical ethics is largely based upon the model presented by 
Beauchamp and Childress in 2001 known as the “Georgetown Mantra,” which is based on 
four basic principles6: 
• Beneficence
• Non-malfeasance
• Respect for autonomy
• Justice
Beneficence is the act of doing good, such as an act of kindness or charity. Derived from 
the root word benefit, it means to bring or create benefit for others. It is altruism in its 
purest sense. The corollary to bringing or creating benefit is to protect from harm or evil. 
The ethical pharmacist has a duty to do good for the patient.
Non-malfeasance is the act of refraining from doing harm. Non-malfeasance is the foun-
dation for the maxim found in the Hippocratic Oath, “first, do no harm,” or primum non 
nocere.7 The underlying principle is to refrain from causing pain, suffering, or loss of life. 
The pharmacist has an ethical duty not to leave the patient worse off than before the treat-
ment. This ethical obligation has historically functioned as a barrier to physician-assisted 
suicide but in furtherance of evolving societal concerns has been subordinated to other 
ethical considerations for autonomy and justice discussed below (see also, California's End 
of Life Options Act, Codified under Health and Safety Code §433 et seq.). An example of 
this might be a terminally ill patient not expected to live beyond one year who will have to 
endure pain and loss of dignity as he/she loses control of normal bodily functions. Such a 
person may now choose to end his/her life to avoid the pain and humility until inevitable 
demise. The patient has a right to choose to end his/her life with the assistance of health 
professionals who may provide medications to accomplish this. This places the pharmacist 
and other health care professionals in an ethical dilema as it creates a conflict between 
ethical mandates: non-malfeasance versus the respect for autonomy.
January/February 2018   California Journal of Health-System Pharmacy     cjhp     17
18     cjhp     California Journal of Health-System Pharmacy  January/February 2018
Clinical Pearls:  Pharmacy Ethics
Respect for autonomy is to honor that the 
patient has the right to choose for him 
or herself according to the individual’s 
beliefs and values. This principle not 
only requires the professional to respect 
the individual’s right to determine their 
own course of therapy but to do so in 
an informed fashion. It implies that 
the patient receives full disclosure of 
the potential benefits and risks of the 
therapy. It is the foundation for the 
concept of informed consent (besides 
avoidance of the risk of being accused 
of the tort of battery). The inference is 
that in providing this disclosure, that the 
pharmacist will also respect the privacy 
and maintain the confidentiality of the 
information on behalf of the patient.
Justice refers to the doctrine of fairness 
and equitable treatment. It deals with the 
equitable distribution of social benefits 
and burdens. Theories of justice in 
bioethics are divided into the theories of 
utilitarian, egalitarian, and libertarian.8 
All of the theories propose a system of 
just distribution of benefits and burdens 
equally without bias or preference. The 
ethical pharmacist is duty bound to 
allocate the benefits of drug therapy 
in a just manner based on objective 
criteria and not influenced by personal 
preference or bias.
Others have divided the ethical principles 
according to whom the duty relates to, 
such as that owed to the consumer, the 
community, the profession, the business, 
and the wider healthcare team.9 Although 
there is logic to identifying these duties 
by stakeholder, the practitioner is left to 
prioritize these duties on their own to 
resolve an ethical dilemma.
Other academicians propose a psycho-
logical theory of cognitive moral 
development (CMD), which is based 
upon an individual’s progression through 
various mental stages of moral develop-
ment over time.10 Kohlberg identifies 
three levels of moral development, with 
two sub-stages within each level, as: 
1)  pre-conventional morality, where deci-
sions are made based on what is best 
for them, with stage 1 consisting of 
punishment avoidance and obedience 
and stage 2 being exchange of favors; 
2)  conventional morality, where decisions 
are made to please others, especially 
authority figures and persons with 
higher status, with stage 3 seeking 
positive feedback or compliments,  
and stage 4 consisting of law and 
order; and 
3)  post-conventional morality, where 
decisions are made based upon 
an abstract principle, with stage 5 
reflecting a social contract, and stage 6 
being universal ethical principle.11 
Again, this theory places moral develop-
ment into “developmental categories” 
but does not provide the practitioner 
with any guidance to resolve an ethical 
dilemma encountered in daily practice. 
Ethical cognition can, however, differen-
tiate between a good and a not-so-good 
pharmacist and can help educators with 
instilling educational values. This is of 
value to academicians who are educating 
pharmacy students before they become 
practicing clinicians.
These concepts seem basic enough for 
pharmacists to follow, but the prob-
lems may arise when there are conflicts 
between moral duty and obligations. 
These moral dilemmas arise when two 
or more conflicting issues arise out of 
a single situation. An example might 
be when a woman seeking to purchase 
emergency contraception approaches 
a pharmacist who subscribes to strict 
Catholic beliefs regarding abortion and 
contraception. The pharmacist is faced 
with the ethical dilemma of pitting the 
adherence to his religious beliefs versus 
his duty to the woman as a patient who is 
seeking him out as a health professional 
for treatment. Sometimes these dilemmas 
involve money. Pharmacists have long 
been challenged between economic and 
medical/professional motivations in 
their daily practice, because of the role of 
the pharmacist as healthcare providers 
and as business managers.12 One study 
demonstrated that pharmacists are 
aware of the ethical issues and possess 
the practical skills required to resolve 
the issues,13 and another study linked 
community pharmacists’ moral reasoning 
with clinical performance, showing that 
pharmacists with a higher capacity for 
moral reasoning demonstrated a higher 
level of clinical performance.14 However, 
it appears that the longer a pharmacist is 
employed in a community setting, appli-
cation of moral reasoning appears  
to erode.15 This may be due in part to  
the “commercialization” of healthcare, 
and the conflicting obligations of duty 
to the employer for profitability and 
managing affordability with beneficence 
and the other elements of  
the “Georgetown Mantra.”12
Pharmacists are faced with ethical chal-
lenges daily in their practice.16 Sometimes 
the question is not whether or not to 
dispense but involves managing noncom-
pliant patients.17 The pharmacist notices 
that a man is noncompliant with his 
antihypertensive medications. Upon 
inquiry, the man admits that he stopped 
taking the medication because of the erec-
tile dysfunction side effect of the drug. 
Although the pharmacist is bound by the 
duty of beneficence, the pharmacist is 
also bound by the obligation to respect 
autonomy and self-determination. After 
a detailed explanation of the conse-
quences, it is ultimately up to the patient 
to determine whether or not to continue 
the treatment. Hospital pharmacists are 
not exempt from these challenges and, 
in fact, may be subjected to additional 
challenges, such as being faced with 
financial constraints or chronic drug 
shortages.18 For example, at the time of 
writing this paper, there is a national 
shortage of sodium bicarbonate for injec-
tion. How is the determination made as to 
which acidotic patients receive infusions 
containing bicarbonate? Of course, the 
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resolution must be determined by an 
inter-professional group who develop 
objective guidelines based on clinical 
criteria, so that the allocation of the 
scarce resources may be carried out fairly. 
The issue of ethics in hospital pharmacy 
practice is not isolated to the United 
States; in 2014, there was a worldwide 
pharmacy meeting to discuss the future of 
hospital pharmacy practices and ethics.19 
Of course, no discussion of ethics could 
be complete in the 21st century without 
a discussion of professional ethics as they 
relate to social media. Individuals will 
cite their rights of freedom of speech 
based upon the first amendment of the 
Constitution; however, the first amend-
ment only prevents the government from 
infringing speech. Even the government 
as an employer can place restrictions as 
a condition of employment.20 In the case 
of McAuliffe v. Mayor of New Bedford, a 
policeman was terminated from the job 
for soliciting for political contributions, 
a violation of police regulations. The 
policeman initiated a lawsuit to be rein-
stated because the police regulation was 
an infringement upon his right to free 
speech, and political speech is among 
the category of speech deserving the 
most protection. The court ruled against 
the policeman’s reinstatement, and in 
his opinion, Justice Holmes stated, “The 
petitioner may have a constitutional 
right to talk politics, but he has no 
constitutional right to be a policeman.”21 
In this age of social media, it is tempting 
to share frustrations at work with one’s 
friends on social media. In doing this, 
extreme care must be taken so as not 
to violate HIPAA. Even if the identity 
of the patient could not be discerned, 
the employer would not be pleased 
upon seeing one of their pharmacists 
complaining about patients or making 
fun of customers in a public forum. This 
reflects poorly on the company, and 
the employer could very convincingly 
argue that such actions would dissuade 
customers from using not only that 
pharmacy but the entire pharmacy 
chain. Some of the postings on social 
media may run afoul of the ethical 
principle of non-malfeasance by 
doing harm to either the subject being 
complained about or ridiculed or injury 
to the reputation and standing in the 
community of the employer. 
Faced with these ethical dilemmas, 
pharmacists and students alike often 
seek one “right” answer. Therein lies a 
significant challenge; there is no single 
“right” answer. Between the good and 
the bad, there lies an infinite number of 
shades of gray.22 
An ethical dilemma, by definition, is the 
conflict between two different ethical 
principles which are mutually exclusive. 
A decision made by an individual 
practitioner may vary based upon that 
individual’s personal beliefs, moral 
conviction, and value systems. To make 
the issue more complex, the goals and 
priorities of employers may conflict 
with the individual practitioner’s values. 
Society provides us with some guidance 
by way of passing laws and regulations 
to facilitate in our decision-making 
when faced with these conflicts.23 One 
such example is California Business & 
Professions Code §733(b)(3), which 
provides the procedures to be followed 
if a pharmacist refuses to fill an order or 
prescription based on ethical, moral, or 
religious grounds.24 However, laws and 
regulations will not cover all the ethical 
dilemmas encountered by the pharmacist 
in his/her daily practice. 
One strategy to develop ethics awareness 
and skills in practitioners is to provide 
additional training. The California State 
Board of Pharmacy adopted a new 
regulation to require that a portion of 
the mandatory continuing education 
hours required for licensure renewal be 
carved out such that two hours involve 
a course in ethics and pharmacy law. 
This is not unusual, as a portion of the 
An ethical dilemma, by 
definition, is the conflict 
between two different 
ethical principles which 
are mutually exclusive. 
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continuing education hours for attor-
neys in California has always included 
mandatory training in ethics, substance 
abuse, and elimination of bias for 
licensure renewal. Given the trend in 
accreditation of schools and colleges for 
the health professions, it would not be 
unreasonable to have these programs 
offered in an inter-professional format.25 
Professionals from different disciplines 
facing the same ethical challenge from 
different perspectives are reflective of 
what occurs in real life, so it makes sense 
that training in ethics should also occur 
in an inter-professional venue. With 
additional training, pharmacists should 
be able to navigate the challenges of 
ethical dilemmas encountered in practice 
by being able to identify and categorize 
the issues that they are facing, and then 
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arrive at a rational conclusion based upon 
prioritization of ethical principles.26
In conclusion, it appears that ethics, or 
the lack or attenuation thereof, is an 
important issue facing practicing phar-
macists today. There are both statutory 
and regulatory provisions to support the 
requirement of ongoing education and 
training in ethics. Evidence of formal 
disciplinary actions by the California State 
Board of Pharmacy faced requiring phar-
macists to take a formal course in ethics 
as a condition of retention of licensure is 
sufficient to demonstrate that pharma-
cists are deviating from the expectations 
consistent with ethical behavior. Periodic 
review of the principles of beneficence, 
non-malfeasance, autonomy, and justice 
would benefit pharmacists in practice, 
as evidence infers that a pharmacist’s 
moral reasoning erodes with time. 
Additional training in ethics may be 
beneficial to the practicing pharmacist, 
particularly since there is evidence 
to support that pharmacists with a 
higher capacity for moral reasoning 
demonstrated a higher level of clinical 
performance. Faced with professionals 
committing ethical breaches compro-
mising their license and the dilemmas 
created by the commercialization of 
healthcare, the California State Board of 
Pharmacy is warranted in their require-
ment that a portion of the 30 hours 
of continuing education required for 
continued licensure be grounded in the 
training of ethics. o
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